ARCHIVES

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

In Brief: Kea, Montes Leave DCPC; Smart Heads Early Detection Branch; Costlow Special Assistant

October 3, 1986

Advocates Oppose Proposals to Market Drugs After Phase I.

June 9, 2006

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011

NCI’s Goal To Increase Minority Participation In Trials, Sondik Says

May 5, 1995

Obituary: Paul Rogers, Former Congressman, Instrumental In National Cancer Act Passage.

October 17, 2008